NCT03638869View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REL-1017 (d-Methadone)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

November 16, 2015

Study Completion Date

November 16, 2015

Conditions
Neuropathic Pain
Interventions
DRUG

REL-1017

The investigational product, REL-1017 is prepared as a solution with Ocean Spray® Diet Cranberry Juice on site to obtain a final volume of 100 mL for dosing. The study drug will be administered as a solution of 25 mg, 50 or 75 mg REL-1017 for 10 days, based on randomization prepared in Ocean Spray® Diet Cranberry Juice with a final volume of 100 mL.

DRUG

Placebo

All Listed Sponsors
lead

Relmada Therapeutics, Inc.

INDUSTRY

NCT03638869 - Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REL-1017 (d-Methadone) | Biotech Hunter | Biotech Hunter